Literature DB >> 35786161

Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease.

Moris Sangineto1,2, Christoph Grander1, Felix Grabherr1, Lisa Mayr1, Barbara Enrich1, Julian Schwärzler1, Marcello Dallio1,3, Vidyasagar Naik Bukke2, Archana Moola2, Antonio Moschetta4, Timon E Adolph1, Carlo Sabbà4, Gaetano Serviddio2, Herbert Tilg1.   

Abstract

Alcohol-related liver disease (ALD) is a major cause of liver disease and represents a global burden, as treatment options are scarce. Whereas 90% of ethanol abusers develop alcoholic fatty liver disease (AFLD), only a minority evolves to steatohepatitis and cirrhosis. Alcohol increases lipogenesis and suppresses lipid-oxidation implying steatosis, although the key role of intestinal barrier integrity and microbiota in ALD has recently emerged. Bacteroides thetaiotaomicron (Bt) is a prominent member of human and murine intestinal microbiota, and plays important functions in metabolism, gut immunity, and mucosal barrier. We aimed to investigate the role of Bt in the genesis of ethanol-induced liver steatosis. Bt DNA was measured in feces of wild-type mice receiving a Lieber-DeCarli diet supplemented with an increase in alcohol concentration. In a second step, ethanol-fed mice were orally treated with living Bt, followed by analysis of intestinal homeostasis and histological and biochemical alterations in the liver. Alcohol feeding reduced Bt abundance, which was preserved by Bt oral supplementation. Bt-treated mice displayed lower hepatic steatosis and triglyceride content. Bt restored mucosal barrier and reduced LPS translocation by enhancing mucus thickness and production of Mucin2. Furthermore, Bt up-regulated Glucagon-like peptide-1 (GLP-1) expression and restored ethanol-induced Fibroblast growth factor 15 (FGF15) down-regulation. Lipid metabolism was consequently affected as Bt administration reduced fatty acid synthesis (FA) and improved FA oxidation and lipid exportation. Moreover, treatment with Bt preserved the mitochondrial fitness and redox state in alcohol-fed mice. In conclusion, recovery of ethanol-induced Bt depletion by oral supplementation was associated with restored intestinal homeostasis and ameliorated experimental ALD. Bt could serve as a novel probiotic to treat ALD in the future.

Entities:  

Keywords:  Alcohol-related liver disease; Bacteroides thetaiotaomicron; intestinal barrier; microbiota; mitochondria; steatosis

Mesh:

Substances:

Year:  2022        PMID: 35786161      PMCID: PMC9255095          DOI: 10.1080/19490976.2022.2089006

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  52 in total

1.  Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage.

Authors:  A Keshavarzian; E W Holmes; M Patel; F Iber; J Z Fields; S Pethkar
Journal:  Am J Gastroenterol       Date:  1999-01       Impact factor: 10.864

2.  Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.

Authors:  Gianluca Svegliati-Baroni; Stefania Saccomanno; Chiara Rychlicki; Laura Agostinelli; Samuele De Minicis; Cinzia Candelaresi; Graziella Faraci; Deborah Pacetti; Marco Vivarelli; Daniele Nicolini; Paolo Garelli; Alessandro Casini; Melania Manco; Geltrude Mingrone; Andrea Risaliti; Giuseppe N Frega; Antonio Benedetti; Amalia Gastaldelli
Journal:  Liver Int       Date:  2011-02-15       Impact factor: 5.828

Review 3.  Metabolic fibroblast growth factors (FGFs): Mediators of energy homeostasis.

Authors:  Kathleen R Markan; Matthew J Potthoff
Journal:  Semin Cell Dev Biol       Date:  2015-09-30       Impact factor: 7.727

4.  Ethanol modulation of intestinal epithelial tight junction barrier.

Authors:  T Y Ma; D Nguyen; V Bui; H Nguyen; N Hoa
Journal:  Am J Physiol       Date:  1999-04

5.  Enteric dysbiosis associated with a mouse model of alcoholic liver disease.

Authors:  Arthur W Yan; Derrick E Fouts; Johannes Brandl; Peter Stärkel; Manolito Torralba; Eckart Schott; Hide Tsukamoto; Karen E Nelson; David A Brenner; Bernd Schnabl
Journal:  Hepatology       Date:  2010-12-10       Impact factor: 17.425

Review 6.  Pathogenesis of alcoholic liver disease: role of oxidative metabolism.

Authors:  Elisabetta Ceni; Tommaso Mello; Andrea Galli
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

7.  Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice.

Authors:  Phillipp Hartmann; Peng Chen; Hui J Wang; Lirui Wang; Declan F McCole; Katharina Brandl; Peter Stärkel; Clara Belzer; Claus Hellerbrand; Hidekazu Tsukamoto; Samuel B Ho; Bernd Schnabl
Journal:  Hepatology       Date:  2013-05-27       Impact factor: 17.425

8.  Hepatic-specific lipin-1 deficiency exacerbates experimental alcohol-induced steatohepatitis in mice.

Authors:  Ming Hu; Huquan Yin; Mayurranjan S Mitra; Xiaomei Liang; Joanne M Ajmo; Karim Nadra; Roman Chrast; Brian N Finck; Min You
Journal:  Hepatology       Date:  2013-10-17       Impact factor: 17.425

9.  GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy.

Authors:  Shvetank Sharma; Jamie E Mells; Ping P Fu; Neeraj K Saxena; Frank A Anania
Journal:  PLoS One       Date:  2011-09-21       Impact factor: 3.240

Review 10.  Trends in the management and burden of alcoholic liver disease.

Authors:  Philippe Mathurin; Ramon Bataller
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.